Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: PANPHARMA
Street 1: ZI du Clairay
Street 2:
City: Trittau
Province:
Post Code: 35133
Country: France
Phone: +33299979212
Email: info@panpharma.fr
Web Site:

Focal Point Contact Information

Salutation: Mr
First Name: Gildas
Last Name: Blonsard
Title: Head of sales
Email: gblonsard@rotexmedica.com
Phone:  

Alternate Focal Point Contact Information

Salutation: Mr
First Name: Michel
Last Name: Lebellego
Title:  
Email: mlebellego@panpharma.fr
Phone:  

General Information

Board Constituency: Private sector
Organization Type - Primary: Private Sector
Organization Type - Secondary: Company
Is your organization legally registered in your country: Yes
Organization Reach: International
Organization Description:
Panpharma is specialyzed in injectables. We are manufacturer of Kanamycine - Streptomycine - Imipenem sourced by UN or NGOs for TB Programms.
We are interested as it is a major line in our production and we are looking to develop the range for TB.
 
Total number of staff in your organization: 100 +
Number of full-time staff who are directly involved with TB: 6 - 10
Number of part-time staff who are directly involved with TB: 0
Number of volunteers who are directly involved with TB: 0
 
What is your organization's annual budget (USD) dedicated to TB? $1 MIL-$10 MIL
How did you hear about the Stop TB Partnership: Other partners
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Information on developments within the TB world
 
Are you a member of a Stop TB national partnership: No
Are you in contact with your national TB programme: No
Please tell us how your organization is contributing to your country's national TB control plan:
NO TB in France
 

Geographical Reach

Which country is your headquarters located in: France
Which WHO region is the main focus of your work: Global
Which countries do you do operate in:
(This includes countries you are conducting activities in)
France
Germany
United Kingdom of Great Britain and Northern Ireland

Specializations

Provision of drugs, diagnostics and commodities

Specializations in Countries

Provision of drugs, diagnostics and commodities France
Provision of drugs, diagnostics and commodities Germany
Provision of drugs, diagnostics and commodities United Kingdom of Great Britain and Northern Ireland

Contribution

Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

New TB Drugs:
We are delivering Kanamycin and Imipenem Cilastatin to Global Found.

Declaration

Declaration of interests:
No conflicts of interest were delacred.

Application date: September 1, 2017
Last updated: September 4, 2017